Neuropharm Report issue

For profit Phase 2 Phase 3
Founded: Leatherhead United Kingdom (2005)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
2007
NCT00515255
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Neuropharm Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

fluoxetine (prozac) (2 trials)

Drugs in Phase 2 Trials (2)

fenobam (1 trial)

minocycline (minocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autistic Disorder (Phase 3)

Compulsive Personality Disorder (Phase 2)

Disease (Phase 2)

Fragile X Syndrome (Phase 2)

Obsessive-Compulsive Disorder (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3